OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001394319

Tracon Pharmaceuticals, Inc.

Tracon Pharmaceuticals, Inc. (CIK 0001394319, EIN 34-2037594) reported revenue of $12.05 million ($12,045,000) for FY2023 (2023-01-01 to 2023-12-31) and net income of -$3.59 million (-$3,588,000) for FY2023 (2023-01-01 to 2023-12-31), as filed in its 10-K filed 2024-03-05 (accession 0000950170-24-026205).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001394319
EIN34-2037594
SIC industry code2836 Biological Products, (No Diagnostic Substances)
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_2cmmcnxr81024hdgacwmbyfwtt
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$12,045,000FY20232023-01-01 to 2023-12-3110-K2024-03-050000950170-24-026205RevenueFromContractWithCustomerExcludingAssessedTax
Net income-$3,588,000FY20232023-01-01 to 2023-12-3110-K2024-03-050000950170-24-026205NetIncomeLoss
Total assets$10,105,000FY2023as of 2023-12-3110-K2024-03-050000950170-24-026205Assets
Stockholders' equity-$809,000FY2023as of 2023-12-3110-K2024-03-050000950170-24-026205StockholdersEquity
Operating cash flow$3,676,000FY20232023-01-01 to 2023-12-3110-K2024-03-050000950170-24-026205NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.11 per shareFY20232023-01-01 to 2023-12-3110-K2024-03-050000950170-24-026205EarningsPerShareDiluted
Shares outstanding45,504,501 sharesFY2023as of 2024-03-0110-K2024-03-050000950170-24-026205EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2014-2023, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20232023-01-01 to 2023-12-31$12,045,00010-K2024-03-050000950170-24-026205
RevenueFY20222022-01-01 to 2022-12-31$010-K2023-03-080001564590-23-003313
RevenueFY20212021-01-01 to 2021-12-31$346,00010-K2024-03-050000950170-24-026205
RevenueFY20202020-01-01 to 2020-12-31$010-K2023-03-080001564590-23-003313
RevenueFY20192019-01-01 to 2019-12-31$010-K2022-03-150001564590-22-010475
RevenueFY20182018-01-01 to 2018-12-31$3,000,00010-K2021-02-250001564590-21-008957
RevenueFY20172017-01-01 to 2017-12-31$8,755,00010-K2020-02-280001564590-20-007520
RevenueFY20162016-01-01 to 2016-12-31$3,449,00010-K2019-03-010001564590-19-005597
Net incomeFY20232023-01-01 to 2023-12-31-$3,588,00010-K2024-03-050000950170-24-026205
Net incomeFY20222022-01-01 to 2022-12-31-$29,135,00010-K2024-03-050000950170-24-026205
Net incomeFY20212021-01-01 to 2021-12-31-$28,667,00010-K2024-03-050000950170-24-026205
Net incomeFY20202020-01-01 to 2020-12-31-$16,775,00010-K2023-03-080001564590-23-003313
Net incomeFY20192019-01-01 to 2019-12-31-$22,674,00010-K2022-03-150001564590-22-010475
Net incomeFY20182018-01-01 to 2018-12-31-$34,959,00010-K2021-02-250001564590-21-008957
Net incomeFY20172017-01-01 to 2017-12-31-$19,103,00010-K2020-02-280001564590-20-007520
Net incomeFY20162016-01-01 to 2016-12-31-$27,008,00010-K2019-03-010001564590-19-005597
Net incomeFY20152015-01-01 to 2015-12-31-$24,410,00010-K2018-03-010001564590-18-003925

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2024-08-132024-06-300000950170-24-096403tcon-20240630.htm
10-Q2024-05-142024-03-310000950170-24-059752tcon-20240331.htm
10-K2024-03-052023-12-310000950170-24-026205tcon-20231231.htm
10-Q2023-11-092023-09-300000950170-23-062204tcon-20230930.htm
10-Q2023-08-142023-06-300000950170-23-042521tcon-20230630.htm
10-Q2023-05-102023-03-310000950170-23-020649tcon-20230331.htm
10-K2023-03-082022-12-310001564590-23-003313tcon-10k_20221231.htm
10-Q2022-11-142022-09-300001564590-22-037664tcon-10q_20220930.htm
10-Q2022-08-102022-06-300001564590-22-028972tcon-10q_20220630.htm
10-Q2022-05-112022-03-310001564590-22-019566tcon-10q_20220331.htm
10-K2022-03-152021-12-310001564590-22-010475tcon-10k_20211231.htm
10-Q2021-11-032021-09-300001564590-21-054044tcon-10q_20210930.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001394319published by the sourcedata.sec.gov/submissions/CIK0001394319.json2026-10-21
Employer Identification Number (EIN) · US-EIN34-2037594published by the sourceaskebsa.dol.gov/FOIA%20Files/2024/Latest/F_5500_SF_2024_Latest.zip2026-10-22
Employer Identification Number (EIN) · US-EIN34-2037594published by the sourcedata.sec.gov/submissions/CIK0001394319.json2026-10-21

Same entity in other Olympus APIs

Records other Olympus APIs serve for this entity, linked through a published identifier (never matched on name).

APIRecordAPI pathLinked through
US Employee Benefits & Form 5500 APIsponsor/v1/form-5500/sponsors/342037594US-EIN 342037594

Former names

NameFromTo
Tracon Pharmaceuticals Inc2007-03-222014-09-15

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001394319.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001394319.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001394319" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001394319/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001394319/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1394319"}

On SEC EDGAR

About this data